Looks like a sound investment to maximize impact of the ind submission.
Despite all the pumping in the past this time they’ve overcome all obstacles.
We are not seeing the caution they’ve always expressed before. A noticeable difference from Professor Gunzburg this time.
There are no longer qualifications or statements about how you can never know what’s going to happen when testing a new cell or technology. Because they are now,finally, unequivocal about having the best possible cell line in terms of reproduction, efficacy, growth and consistency.
It an important change in the messaging.
They have clearly said the testing of the first part of the staggered production is the last thing they need to complete the ind and that they are very happy with the cell product and how it’s growing and working. That’s a big change in the messaging. That first stage should be competed and tested by now. They should be compiling the information of its testing into the ind very soon as the assay is delivered from the testing labs.
Now there is money committed to the promotion of the company because they have a story to tell that isn’t a maybe. They will have submitted their ind and they want everyone to know because they need to sell some shares to raise funds for CRO and everything else.
The one thing we should be concerned about imho is that those buyers of shares for 1 cent could quickly dump some of their shares as they have so many and this could stop the share price going up to where it deserves to go.
Because the really big share price will cone when we have lifesaving results. But if you own 100 million shares at 1 cent each why wouldn’t you dump 20 million and take say ten million off the table when it goes to 50 cents. The problem with that is that it may never go higher. Because if the share price remains flat or goes down in the face of great news. New investors will avoid it. Let’s hope those big shareholders will manage their exit very carefully. For fear of shooting themselves and all of us in the foot.
The other thing is that kw might award himself a new raise or bonus without running it past shareholders. I believe this would be unacceptable. He’s been paid and awarded shares without milestones so he shouldn’t get more if milestones are met. It’s not fair to have it both ways.
Let’s hope Thomas Yuen has a say in this.
Submitting the ind will be a wonderful achievement but kw has already been well rewarded for this.
News 
Market Data 
Discover 
